Impact of novel therapies for mantle cell lymphoma in the real world setting: a report from the UK's Haematological Malignancy Research Network (HMRN)

The treatment landscape for mantle cell lymphoma (MCL) has changed dramatically in recent years, with findings from clinical trials reporting improvements in survival. Data on the general patient population are, however, sparse; and it is unclear whether the effects observed in clinical trials have...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Alexandra, Roman, Eve, Appleton, Simon, Howell, Debra, Johnson, Rod, Burton, Cathy, Patmore, Russell
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Haematological Malignancy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947165/
https://www.ncbi.nlm.nih.gov/pubmed/29532919
http://dx.doi.org/10.1111/bjh.15170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5947165/
https://www.ncbi.nlm.nih.gov/pubmed/29532919
http://dx.doi.org/10.1111/bjh.15170

Ejemplares similares